Dong Guo

2.1k total citations · 1 hit paper
19 papers, 945 citations indexed

About

Dong Guo is a scholar working on Molecular Biology, Neurology and Infectious Diseases. According to data from OpenAlex, Dong Guo has authored 19 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Infectious Diseases. Recurrent topics in Dong Guo's work include Respiratory viral infections research (3 papers), Phytochemical compounds biological activities (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Dong Guo is often cited by papers focused on Respiratory viral infections research (3 papers), Phytochemical compounds biological activities (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Dong Guo collaborates with scholars based in China, United States and Canada. Dong Guo's co-authors include Yu Zhou, Yingle Liu, Yong Xiong, Mǎng Shī, Dehe Wang, Yuan Liu, Ke Lan, Ming Guo, Wenjia Hu and Liu Cao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Society of Nephrology and Life Sciences.

In The Last Decade

Dong Guo

17 papers receiving 930 citations

Hit Papers

Transcriptomic characteristics of bronchoalveolar lavage ... 2020 2026 2022 2024 2020 250 500 750

Peers

Dong Guo
Dong Guo
Citations per year, relative to Dong Guo Dong Guo (= 1×) peers Yingjie Qi

Countries citing papers authored by Dong Guo

Since Specialization
Citations

This map shows the geographic impact of Dong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Guo more than expected).

Fields of papers citing papers by Dong Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Guo. The network helps show where Dong Guo may publish in the future.

Co-authorship network of co-authors of Dong Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Guo. A scholar is included among the top collaborators of Dong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Guo. Dong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cao, Fei, Yangzhouyun Xie, Dong Guo, et al.. (2025). High Phosphate and Low Protein Mediate Arterial and Cutaneous Vascular Calcification in CKD Mice. Journal of the American Society of Nephrology.
2.
Deng, Jie, Xiaoyan Wu, Jian Li, et al.. (2025). Peptides targeting RAB11A–FIP2 complex inhibit HPIV3, RSV, and IAV replication as broad-spectrum antivirals. Cell & Bioscience. 15(1). 50–50. 1 indexed citations
3.
Guo, Dong, et al.. (2024). Non-targeted screening and toxicity study of safety risk substances in facial skincare products: Molecular networking and computational toxicology strategy. SHILAP Revista de lepidopterología. 1(4). 100055–100055. 1 indexed citations
5.
Li, Bohao, et al.. (2024). Understanding the mechanisms and treatments of long COVID to address future public health risks. Life Sciences. 353. 122938–122938. 2 indexed citations
6.
Lin, Xiaoyuan, Yan Xiong, Weiwei Xue, et al.. (2024). Yip1 interacting factor homolog B mediates the unconventional secretion of ORF8 during SARS-CoV-2 infection. iScience. 28(1). 111551–111551.
7.
Guo, Dong, et al.. (2021). Efficacy and safety of Xinkeshu in the treatment of angina pectoris of coronary heart disease. Medicine. 100(40). e27407–e27407. 1 indexed citations
8.
Guo, Dong, et al.. (2021). Efficacy and safety of Shugan Jieyu capsule in the treatment of essential hypertension with insomnia, anxiety or depression. Medicine. 100(8). e24856–e24856. 9 indexed citations
9.
Guo, Dong, et al.. (2021). Efficacy and safety of Xuanfei Baidu granules for treating COVID-19. Medicine. 100(20). e25653–e25653. 9 indexed citations
10.
Xiong, Yong, Yuan Liu, Liu Cao, et al.. (2020). Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerging Microbes & Infections. 9(1). 761–770. 782 indexed citations breakdown →
12.
Xiong, Yong, Yuan Liu, Liu Cao, et al.. (2020). Transcriptomic Characteristics of Bronchoalveolar Lavage Fluid and Peripheral Blood Mononuclear Cells in COVID-19 Patients. SSRN Electronic Journal. 32 indexed citations
13.
Guo, Dong, et al.. (2019). PI4KB on Inclusion Bodies Formed by ER Membrane Remodeling Facilitates Replication of Human Parainfluenza Virus Type 3. Cell Reports. 29(8). 2229–2242.e4. 20 indexed citations
14.
Yu, Nan‐Nan, et al.. (2012). The Effects of Sperminated Pullulans on Cornea Permeability to Puerarin and the Toxicity. Journal of Ocular Pharmacology and Therapeutics. 28(5). 497–501. 2 indexed citations
16.
Huo, Changhong, Dong Guo, Wei Wang, et al.. (2010). One new limonoid from seeds of Xylocarpus granatum.. Zhongcaoyao. 41(2). 176–178. 2 indexed citations
17.
Guo, Dong. (2009). Effect of atorvastatin on renal function in patients given contrast medium after interventional procedures. 4 indexed citations
18.
Guo, Dong, et al.. (2009). Chemical Constituents of Plants from the Genus Xylocarpus. Chemistry & Biodiversity. 6(9). 1293–1308. 27 indexed citations
19.
Guo, Dong, et al.. (2009). Xylocarpanoids A and B, unique C28 skeleton limonoids from Xylocarpus granatum. Tetrahedron Letters. 51(4). 754–757. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026